Johnson & Johnson

Product and Operating Company News

Need to know more about a new skin care product? A new surgical device? A new pain relief medication? You can search here for the information you need from a Johnson & Johnson company.

This section contains multiple pages. Click on each page number to advance the page.

< Prev | | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | .... 34 Next >

New Phase 3 Study Results Show Anti-TNF SIMPONI® Induced Clinical Response in Adults with Moderately To Severely Active Ulcerative Colitis

May 21, 2012

ZYTIGA® (abiraterone acetate) Data to be Presented at 2012 American Society of Clinical Oncology (ASCO) Annual Meeting

May 18, 2012

Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide Pain Management for Patients with Diabetic Peripheral Neuropathy (DPN)

May 17, 2012

Study Reports Catheter Ablation Superior to Drug Therapy as First-Line Treatment

May 11, 2012

Biosense Webster Announces Launch of the THERMOCOOL® SF NAV Catheter With Curve Visualization

May 10, 2012

The Aveeno Brand and The Skin Cancer Foundation Challenge Melanoma Epidemic with 5th Annual Road to Healthy Skin Tour

May 09, 2012

< Prev | | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | .... 34 Next >

Employees

This site is governed solely by applicable U.S. laws and governmental regulations. Please see our Privacy Policy. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy. Your use of the information on this site is subject to the terms of our Legal Notice. You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson Services, Inc. Contact Us with any questions or search this site for more information.
All contents © Copyright Johnson & Johnson Services, Inc.1997-2013. All Rights Reserved.